Hidradenitis Suppurativa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast  2023-2033

Hidradenitis Suppurativa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033

Report Format: PDF+Excel | Report ID: SR112023A7127
Buy Now

The hidradenitis suppurativa market has been comprehensively analyzed in IMARC's new report titled "Hidradenitis Suppurativa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033". Hidradenitis suppurativa, also referred to as acne inversus, is a chronic, painful inflammatory skin condition that causes lumps to develop beneath the skin. These lumps generally form in areas where the skin rubs against itself, such as the groin, armpits, breasts, and buttocks. The condition tends to remain for an extended period and worsen over time, seriously affecting everyday life and emotional health. Individuals suffering from hidradenitis suppurativa may experience painful pea-sized lumps, leaking bumps or sores, blackheads, and tunnels under the skin. The other common symptoms include abscess, excessive sweating, body odor, itching, pimples, pus, swelling, etc. In severe cases, the disease can lead to significant discomfort, reduced mobility, and impaired quality of life. The diagnosis of this ailment is mainly based on medical history and the underlying symptoms. The healthcare professional may examine the affected skin region and sometimes test an infected part's sample. Additionally, various diagnostic procedures, such as ultrasound, magnetic resonance imaging (MRI), biopsy, etc., are further required to identify the extent of the disease.

The rising incidences of blocked hair follicles caused by several risk factors, including hormonal imbalances like polycystic ovarian syndrome, bacterial colonization, obesity, etc., are primarily driving the hidradenitis suppurativa market. Moreover, the increasing prevalence of genetic disorders that alter cell structure and cause immune dysfunction is further augmenting the market growth. Apart from this, the widespread adoption of antiandrogen therapy with spironolactone for treating the ailment, since it inhibits androgens from binding to androgen receptors and prevents cancer cells from growing, is acting as another growth-inducing factor. Furthermore, the inflating utilization of biologics, such as TNF-alpha inhibitors, which relieve disease symptoms by blocking the signaling pathway of a protein involved in the inflammatory process, is also bolstering the market growth. Additionally, several key players are making significant investments in developing imaging techniques that can help identify the extent and severity of the disease and can be particularly useful for assessing deep-seated lesions. This, in turn, is further creating a positive outlook for the market. Moreover, the escalating demand for advanced surgical procedures, such as cryoinsufflation, to effectively treat smaller lesions, especially those in areas where surgery may be difficult or for patients who cannot tolerate more invasive procedures, is also expected to bolster the hidradenitis suppurativa market in the coming years.

IMARC Group's new report provides an exhaustive analysis of the hidradenitis suppurativa market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for hidradenitis suppurativa and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the hidradenitis suppurativa market in any manner.

Time Period of the Study

  • Base Year: 2022
  • Historical Period: 2017-2022
  • Market Forecast: 2023-2033
     

Countries Covered

  • United States
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Japan
     

Analysis Covered Across Each Country

  • Historical, current, and future epidemiology scenario
  • Historical, current, and future performance of the hidradenitis suppurativa market
  • Historical, current, and future performance of various therapeutic categories in the market
  • Sales of various drugs across the hidradenitis suppurativa market
  • Reimbursement scenario in the market
  • In-market and pipeline drugs
     

This report also provides a detailed analysis of the current hidradenitis suppurativa marketed drugs and late-stage pipeline drugs.

In-Market Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Drug Uptake and Market Performance    
     

Late-Stage Pipeline Drugs

  • Drug Overview
  • Mechanism of Action
  • Regulatory Status
  • Clinical Trial Results
  • Regulatory Status   

Key Questions Answered in this Report

Market Insights

  • How has the hidradenitis suppurativa market performed so far and how will it perform in the coming years?
  • What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
  • What was the country-wise size of the hidradenitis suppurativa market across the seven major markets in 2022 and what will it look like in 2033?
  • What is the growth rate of the hidradenitis suppurativa market across the seven major markets and what will be the expected growth over the next ten years?
  • What are the key unmet needs in the market?
     

Epidemiology Insights

  • What is the number of prevalent cases (2017-2033) of hidradenitis suppurativa across the seven major markets?
  • What is the number of prevalent cases (2017-2033) of hidradenitis suppurativa by age across the seven major markets?
  • What is the number of prevalent cases (2017-2033) of hidradenitis suppurativa by gender across the seven major markets?
  • How many patients are diagnosed (2017-2033) with hidradenitis suppurativa across the seven major markets?
  • What is the size of the hidradenitis suppurativa patient pool (2017-2022) across the seven major markets?
  • What would be the forecasted patient pool (2023-2033) across the seven major markets?
  • What are the key factors driving the epidemiological trend of hidradenitis suppurativa?
  • What will be the growth rate of patients across the seven major markets?
     

Hidradenitis Suppurativa: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

  • What are the current marketed drugs and what are their market performance?
  • What are the key pipeline drugs and how are they expected to perform in the coming years?
  • How safe are the current marketed drugs and what are their efficacies?
  • How safe are the late-stage pipeline drugs and what are their efficacies?
  • What are the current treatment guidelines for hidradenitis suppurativa drugs across the seven major markets?
  • Who are the key companies in the market and what are their market shares?
  • What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the hidradenitis suppurativa market?
  • What are the key regulatory events related to the hidradenitis suppurativa market?
  • What is the structure of clinical trial landscape by status related to the hidradenitis suppurativa market?
  • What is the structure of clinical trial landscape by phase related to the hidradenitis suppurativa market?
  • What is the structure of clinical trial landscape by route of administration related to the hidradenitis suppurativa market?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Hidradenitis Suppurativa Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast  2023-2033
Select License Type



Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More